Functional identification and molecular cloning of a human brain vesicle monoamine transporter
about
Association study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese populationVMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuseDistinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporterVisualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesiclesVesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistryVesicular monoamine transporter 2: role as a novel target for drug developmentExpression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumorsActive transport of acetylcholine by the human vesicular acetylcholine transporterVesicular integrity in Parkinson's diseaseThe Concise Guide to PHARMACOLOGY 2013/14: transporters.Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivoProteomics of dense core secretory vesicles reveal distinct protein categories for secretion of neuroeffectors for cell-cell communication.Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences.Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine ToxicityA phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles.Proton-dependent multidrug efflux systems.Cloning and expression of the vesamicol binding protein from the marine ray Torpedo. Homology with the putative vesicular acetylcholine transporter UNC-17 from Caenorhabditis elegans.N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND.Serotonin and serotonin transport in the regulation of lactation.Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters.Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.An investigation of noradrenaline uptake and release by the CATH.a cell line.Role of endocrine cell microvesicles in intercellular chemical transduction.U-373 MG glioblastoma and IMR-32 neuroblastoma cell lines express the dopamine and vesicular monoamine transporters.Expression of a bovine vesicular monoamine transporter in COS cells.High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells.Peptide mapping of the [125I]Iodoazidoketanserin and [125I]2-N-[(3'-iodo-4'-azidophenyl)propionyl]tetrabenazine binding sites for the synaptic vesicle monoamine transporter.Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes.Assignment of the mouse vesicular monoamine transporter genes, Slc18a1 and Slc18a2, to chromosomes 8 and 19 by linkage analysis.Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2.Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.The vesicular monoamine transporter 2 (VMAT2) is expressed by normal and tumor cutaneous mast cells and Langerhans cells of the skin but is absent from Langerhans cell histiocytosis.VMAT1/2 can mediate the transport of biogenic aminesVesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis.
P2860
Q21203891-7EA9773C-0CDB-4E2C-A912-1E8B7652A122Q22242306-89DD7066-80D4-4897-83A0-C028EA9A0F04Q24314400-47AB6339-2CAC-424C-803B-7647B96C0583Q24567830-C536568A-FCE0-4D62-A39C-6FC93FE6097EQ24601233-59911D2F-1F0A-47A7-9DA9-90204782F825Q24647764-4F277D0B-BA96-4F28-BCFE-768418D71C18Q28188312-3C7E4123-E6CD-45B8-8585-0D9CAA4A9A6EQ28296121-8DCFBE92-83AE-4DDF-AFC0-3AED8DD10657Q28385737-E4DE769B-6F53-47C8-9B11-65B0E5AB9DECQ30486743-85A6D9BB-6A5F-44CD-8693-0A39918F807DQ33738102-84F332C4-FB67-475E-A6FF-B1887B6EECD4Q33919548-723C9666-DA14-4C4D-96E9-EED8D3C036AFQ34376138-832C5C62-D714-4DB9-BAD7-C6943BC3CDD3Q35356784-D9D33321-2F6B-4169-9BFF-35C837C42B58Q35810975-2D6B4948-5DF4-4838-B6D5-238857C7BADBQ36328380-1909D0EC-4D23-443B-BD78-B378F91232CAQ36672016-A016F004-B262-46B5-B4D2-8491EAD78C9FQ36745944-339E4C10-BEE7-4514-A336-5BB31E715076Q37589110-F1187F72-C753-4322-82E9-6EEF80429A2BQ37721505-5B57BE3D-148E-4696-96C9-0F60C9B66416Q38153630-C567DE37-B3E3-440B-A131-535F6D40282BQ38602413-85911586-2D07-402A-B8C9-1EC59A5A50ADQ38926644-0CF906ED-42B1-45A1-8699-B9E72EBDE522Q40327489-DD94E2EC-F368-4D38-9BC6-E44C8CF42561Q40904197-D849BADD-015F-43EE-BF99-10FAA907B575Q41044238-D47CF142-9363-4F48-B932-18025E936605Q41179057-74C505B2-07E3-432A-94B8-2F4BB751C25EQ41474660-1760B86B-0EC1-4A4C-AA92-C1C7CFFA30FAQ41961292-A3DD65D5-DBA5-477F-AD85-37CC0067B341Q42061556-BF4C1EA3-22BC-406A-B7F2-C52B6128D643Q43824680-C7887263-9308-4815-929E-D771DD9620A0Q44357603-BC2C7C49-2B32-4635-898F-198134684C31Q46154132-E4152198-B3E2-4D23-9FF1-B01E80AE0054Q46833644-7FE5823D-AFDE-4F94-8677-57FBBBEBE9CCQ46900351-D329B199-2626-4400-9294-42815C20CDDAQ47585008-4334B84D-ECF9-475F-8DFF-286472C25EB3Q50299533-00E46181-8365-4B6D-B4D7-51EABDD12D0AQ54647310-81F9D28B-F79A-41C8-B4AA-38356B203D2A
P2860
Functional identification and molecular cloning of a human brain vesicle monoamine transporter
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Functional identification and ...... vesicle monoamine transporter
@ast
Functional identification and ...... vesicle monoamine transporter
@en
Functional identification and ...... vesicle monoamine transporter
@nl
type
label
Functional identification and ...... vesicle monoamine transporter
@ast
Functional identification and ...... vesicle monoamine transporter
@en
Functional identification and ...... vesicle monoamine transporter
@nl
prefLabel
Functional identification and ...... vesicle monoamine transporter
@ast
Functional identification and ...... vesicle monoamine transporter
@en
Functional identification and ...... vesicle monoamine transporter
@nl
P2860
P1476
Functional identification and ...... vesicle monoamine transporter
@en
P2093
J D Erickson
P2860
P304
P356
10.1111/J.1471-4159.1993.TB07476.X
P407
P577
1993-12-01T00:00:00Z